Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

What COPD actually is

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

COPD is a lung condition in which airflow out of the lungs is persistently limited, by a combination of inflamed, narrowed small airways and destroyed air sacs.

It is not contagious. It is largely preventable, it cannot be reversed, and the decline in lung function can be slowed considerably, chiefly by stopping smoking.

Poster comparing healthy lungs with COPD-damaged lungs, showing a man coughing, with lists of common symptoms, the two types of COPD, risk factors, complications and management steps.
Inflamed, narrowed airways and damaged air sacs together make it hard to push air out.Created for OwieClear.

Related pages: COPD (chronic lung disease)

The bottom line

What we know
  • COPD combines small airway disease and destruction of air sacs.
  • The airflow limitation does not fully reverse, which distinguishes it from asthma.
  • Smoking is the dominant cause, but about one in four people with COPD never smoked.
  • It is not contagious and cannot be caught from anyone.
  • Stopping smoking is the only intervention that changes the rate of lung function decline.
What is still open
  • Why some heavy smokers never develop it.
  • How much early-life lung development contributes.
  • Whether any drug yet slows the decline in lung function.

The story, step by step

  1. 1. The name ()
  2. 2. The obstruction ()
  3. 3. Who gets it ()
  4. 4. What changes it ()
  5. 5. The outlook ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

What the letters mean

Review of many studies

What happens

Chronic, obstructive, pulmonary, disease.

What the research shows

  • Chronic: it is long-term and does not go away between episodes.
  • Obstructive: air leaves the lungs more slowly than it should. The problem is getting air out, not in.
  • Pulmonary: it affects the lungs.
  • Emphysema and chronic bronchitis are the two traditional components, and most people have both to some degree rather than one or the other.
  • Chronic bronchitis is defined by a productive cough on most days for three months of the year, in two consecutive years.
  • Emphysema is destruction of the walls between air sacs, producing fewer, larger, floppier spaces that empty poorly.

Why it matters

Hearing emphysema and chronic bronchitis as separate diagnoses causes confusion. They are two faces of one process, usually present together.

What's still uncertain

  • Whether the traditional subdivision remains clinically useful.
  • How best to classify COPD phenotypes.

Read more

Next: The obstruction

Part 2 of 5

Why air gets trapped

Review of many studies

What happens

Breathing out is the problem.

What the research shows

  • Small airways become inflamed, thickened and clogged with mucus, narrowing the passages.
  • Destroyed air sacs lose their elastic recoil, which is the spring that normally pushes air out. Without it, the airways collapse during exhalation.
  • Air that should leave stays behind, which is air trapping. The lungs become progressively overinflated.
  • Overinflated lungs flatten the diaphragm, which then works at a mechanical disadvantage, so breathing takes more effort.
  • This is why people with COPD naturally breathe out through pursed lips. It keeps the airways open long enough to empty.
  • The limitation does not fully reverse with a bronchodilator, which is exactly how spirometry distinguishes it from asthma.

Why it matters

Understanding that the problem is emptying rather than filling makes sense of almost every symptom and almost every treatment.

What's still uncertain

  • How much of the obstruction is potentially reversible early on.
  • Why small airways are affected first.

Read more

Next: Who gets it

Part 3 of 5

Not only smokers

Review of many studies

What happens

A quarter never smoked.

What the research shows

  • Smoking is the dominant cause in high-income countries, and the risk rises with the amount and duration.
  • Roughly a quarter of people with COPD have never smoked. Their disease comes from biomass smoke, occupational dust and fumes, air pollution, childhood respiratory illness or genetics.
  • Worldwide, indoor smoke from cooking and heating fires is a major cause, affecting women disproportionately.
  • Alpha-1 antitrypsin deficiency is an inherited cause producing emphysema at a young age, often under 45, and is substantially under-diagnosed.
  • Poor lung growth in childhood, from prematurity, severe infections or secondhand smoke, leaves a lower peak lung function, so normal age-related decline reaches the COPD threshold sooner.
  • Not everyone who smoks develops COPD, which points to genetic susceptibility that is only partly understood.

Why it matters

The assumption that COPD means smoking delays diagnosis in the people who never did, and it adds blame to the people who did.

What's still uncertain

  • Why susceptibility differs so much between smokers.
  • How much early-life lung development contributes at population level.

Read more

Next: What changes it

Part 4 of 5

The one disease-modifying step

Review of many studies

What happens

Quitting, and not much else.

What the research shows

  • Lung function declines with age in everyone. In COPD it declines faster.
  • Stopping smoking is the only intervention shown to slow that rate of decline. It does not restore what is lost, but it changes the slope.
  • Inhalers improve symptoms, exercise capacity and exacerbations, and do not clearly alter the long-term decline in lung function.
  • Pulmonary rehabilitation improves breathlessness and exercise capacity more than any drug does, and is substantially under-used.
  • Preventing exacerbations matters, because each severe one is associated with an accelerated loss of function and a worse outlook.
  • Vaccination, oxygen where indicated, and treating other conditions all contribute to how well people live with it.

Why it matters

The ranking is worth being blunt about: quitting first, rehabilitation second, inhalers third. Most people are offered them in the reverse order.

What's still uncertain

  • Whether any drug slows functional decline.
  • How much exacerbation prevention preserves lung function.

Read more

Next: The outlook

Part 5 of 5

Serious, and highly variable

Review of many studies

What happens

Not a fixed timeline.

What the research shows

  • COPD is a leading cause of death worldwide, and it is also a condition many people live with for decades.
  • Outlook depends on lung function, symptoms, exacerbation frequency, exercise capacity, weight and other conditions, not on any single number.
  • Someone with moderate COPD who stops smoking, exercises and avoids exacerbations may remain stable for many years.
  • Severity scores combining breathlessness, exercise capacity, airflow and body mass predict outcomes better than spirometry alone.
  • Most people with COPD die of something else, most commonly cardiovascular disease or lung cancer.
  • Survival figures found online are usually drawn from older cohorts and from people with advanced disease, and they frighten people with mild disease unnecessarily.

Why it matters

A diagnosis of mild COPD in someone who then stops smoking is a very different situation from the statistics that come up when they search for it.

What's still uncertain

  • How much modern treatment has changed survival.
  • Which prognostic tools perform best.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.